IQVIA Holdings Inc.
General ticker "IQV" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $31.7B (TTM average)
IQVIA Holdings Inc. follows the US Stock Market performance with the rate: 63.5%.
Estimated limits based on current volatility of 1.0%: low 238.56$, high 243.48$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 88000 as of 2024
- North and South America accounted for 47.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Loss or delay of contracts, Underpricing/overpricing risks, Infrastructure disruption, Liability from services, Interest rate fluctuations
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [168.38$, 247.86$]
- 2025-12-31 to 2026-12-31 estimated range: [165.41$, 245.59$]
Financial Metrics affecting the IQV estimates:
- Negative: with PPE of 17.7 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 14.29
- Negative: negative Industry operating cash flow (median)
- Positive: 6.63 < Operating cash flow per share per price, % of 7.61
- Positive: 19.35 < Shareholder equity ratio, % of 22.55 <= 42.53
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 4.84
- Positive: -4.41 < Investing cash flow per share per price, % of -4.04
- Negative: negative Industry operating income (median)
- Positive: Inventory ratio change, % of 0.37 <= 0.82
- Positive: Industry inventory ratio change (median), % of -0.84 <= -0.18
Short-term IQV quotes
Long-term IQV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $14,410.00MM | $14,984.00MM | $15,405.00MM |
| Operating Expenses | $12,611.00MM | $13,007.00MM | $13,203.00MM |
| Operating Income | $1,799.00MM | $1,977.00MM | $2,202.00MM |
| Non-Operating Income | $-436.00MM | $-518.00MM | $-533.00MM |
| Interest Expense | $416.00MM | $672.00MM | $670.00MM |
| Income(Loss) | $1,363.00MM | $1,459.00MM | $1,669.00MM |
| Taxes | $260.00MM | $101.00MM | $301.00MM |
| Other Income(Loss) | $-12.00MM | $0.00MM | $5.00MM |
| Profit(Loss)* | $1,091.00MM | $1,358.00MM | $1,373.00MM |
| Stockholders Equity | $5,765.00MM | $6,112.00MM | $6,067.00MM |
| Assets | $25,337.00MM | $26,681.00MM | $26,899.00MM |
| Operating Cash Flow | $2,260.00MM | $2,149.00MM | $2,716.00MM |
| Capital expenditure | $674.00MM | $649.00MM | $602.00MM |
| Investing Cash Flow | $-2,006.00MM | $-1,603.00MM | $-1,444.00MM |
| Financing Cash Flow | $-329.00MM | $-382.00MM | $-878.00MM |
| Earnings Per Share** | $5.82 | $7.39 | $7.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.